Medscape Pharma Private Limited
About Medscape Pharma Private Limited
Data last updated:
Medscape Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 02 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24290TN2021PTC143874.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Narayana Pillai Reghoothama Panicker and Chaniyilparampu Nanappan Ramchand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.153 First Main Road Industrial Estate Perungudi Sholinganalur Taluk, Chennai, Tamil Nadu, India – 600096.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.83 Lakh, a decline of 83% compared to the previous year. For the same year it recorded a net profit of ₹2.83 Lakh (net margin 8.6%) and EBITDA of ₹2.83 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years.
Company details
Contact details
Medscape Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.153 First Main Road Industrial Estate Perungudi Sholinganalur Taluk, Chennai, Tamil Nadu, India – 600096
- IndustryLife Sciences, Biotechnology
To see the full contact details of Medscape Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medscape Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medscape Pharma Private Limited, buy the company report.
Financials of Medscape Pharma Private Limited
FY 2025 filings availableMedscape Pharma Private Limited reported revenue of ₹32.83 Lakh (down 83% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 83% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 55%. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.83 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.83 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.6% | |||
| Net Profit Margin | 8.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medscape Pharma Private Limited, buy the company report.
Board of directors of Medscape Pharma Private Limited
Medscape Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narayana Pillai Reghoothama Panicker Also directs: Accel Limited, Cybolt Technologies Private Limited, Secureinteli Technologies Private Limited and 2 more | Director | 02 Jun 2021 | 5 Years 4 Months | Current |
| Chaniyilparampu Nanappan Ramchand Also directs: Simazz Therapeutics Private Limited, Apamar Biotech Private Limited, Maggenome Technologies Private Limited and 1 more | Director | 02 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Medscape Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kiranglobal Silicachem Private Limited | ₹33.09 Lakh (FY 2025) | 138.0% | Chennai, Tamil Nadu, India | |||
| Medscape Pharma Private Limitedthis company | ₹32.83 Lakh (FY 2025) | ₹2.83 Lakh | 8.6% | -83.0% | Chennai, Tamil Nadu, India | |
| Chirayu Gases Private Limited | ₹32.74 Lakh (FY 2025) | -29.0% | Bhopal, Madhya Pradesh, India | |||
| Salem Lakshmi Dyes and Chemicals Private Limited | ₹32.46 Lakh (FY 2024) | 1.0% | Salem, Tamil Nadu, India |
To see the full peer comparison of Medscape Pharma Private Limited, buy the company report.
Auditor
Medscape Pharma Private Limited is audited by V D S R & CO.,LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V D S R & CO.,LLP | FY 2023 | S200085 |
Shareholding
The shareholding of Medscape Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medscape Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medscape Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medscape Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medscape Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medscape Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Arumugam Sivaraman ceased to be Director on 18 Oct 2021.
Frequently asked questions
Medscape Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 02 June 2021 (5+ years old) and is registered under CIN U24290TN2021PTC143874.
Medscape Pharma has 2 current directors:
- Narayana Pillai Reghoothama Panicker - Director
- Chaniyilparampu Nanappan Ramchand - Director
The latest financial statements of Medscape Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Medscape Pharma is U24290TN2021PTC143874. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medscape Pharma was incorporated on 02 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Medscape Pharma by revenue are Kiranglobal Silicachem Private Limited, Chirayu Gases Private Limited, Salem Lakshmi Dyes and Chemicals Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arumugam Sivaraman ceased to be Director on 18 Oct 2021. Chaniyilparampu Nanappan Ramchand was appointed as Director on 02 Jun 2021. Narayana Pillai Reghoothama Panicker was appointed as Director on 02 Jun 2021.
The registered office of Medscape Pharma is at Plot No.153 First Main Road Industrial Estate Perungudi Sholinganalur Taluk, Chennai, Tamil Nadu, India – 600096.
Medscape Pharma operates in the life sciences industry, in the biotechnology segment.
Medscape Pharma can be reached at its registered office: Plot No.153 First Main Road Industrial Estate Perungudi Sholinganalur Taluk, Chennai, Tamil Nadu, India – 600096.
Medscape Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.